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Introduction
Genomic DNA of every cell of an organism is subjected to mutational pressure by environmental factors, such as ionizing irradiation and chemical mutagens, as well internal factors, including mistakes by cellular replication and repair machinery. The known cellular DNA repair mechanisms replace damaged or incorrect DNA bases and rejoin ends of DNA after single-strand and doublestrand breaks (SSB and DSB) after mutational events [1] . When the damage is rather long and affects both DNA chains, its repair becomes problematic and the damage often results in a mutation. DSB is an example of the damage that is difficult to repair as it affects both cellular chromosomal integrity and genomic sequences. A quick non-sequence-specific double-strand break repair mechanism employing KU70-KU80 proteins and nuclear DNA-dependent protein kinase joins broken ends and restores the genomic integrity [2] . It is unable to restore bases or short DNA fragments that can be missing from the broken DNA ends. Besides, it may join incorrect ends in the case of multiple DSBs in the nucleus, which results in chromosome aberrations, making such DSB repair itself a source of mutations [1, 3] .
The only error-free DSB-repair mechanism in cells is homologous recombination (HR), which restores the status quo in genomic DNA via a slow, multi-step, complex, but highly accurate process using as template for the repair either a sister chromatid after DNA doubling in the G2 period of the cell cycle or a homologous chromosome [1] . This mechanism is considered crucial for DSB repair and predominant in unicellular organisms such as the yeast Saccharomyces cerevisiae. It appears that both inaccurate end-joining and HR participate in DSB repair in vertebrate cells and the share of each mechanism probably depends on the number of DSBs per cell. It was found that generating DSBs via transient in vivo expression of restriction endonuclease SceI in mammalian cells resulted in a sharp 2,000 -10,000-fold increase of conversional repair of an inactivated gene containing I-SceI restriction site via HR mechanism [4] . In a similar system homologous repair accounted for 30-50% of observed DSB repair events [5] . Another work demonstrated that in vivo restriction endonuclease treatment of cellular chromatin in mammalian cells can increase nonhomologous integration of plasmid DNA 5-fold and inhibit homologous integration 2-fold suggesting that multiple DNA breaks attract illegitimate recombination that competes with the homology search [6] . This may indicate that the accurate and slow HR is likewise saturable, so when severe mutagenic damage with excessive DSBs in cells occurs, the non-homologous end joining becomes predominant mechanism of the repair, while HR may still lead in DSB repair in normal conditions. In any case in mammals, mutations in the genes encoding the proteins of homologous recombination induce either embryonic lethality or strong X-ray sensitivity and predisposition to cancer, suggesting the importance of HR in post-irradiation damage repair [1, 7, 8] . In fact, soon after -irradiation of mammalian cells induced DSBs, multiple nuclear foci containing the RAD52 epistasis group of proteins relating to HR were observed in cell nuclei reflecting activation of the repair pathway [9] .
Although ionizing irradiation is a known mutagenic agent affecting both DNA sequences and DNA integrity in cells, the mechanism of its damage to an organism remains unclear. Extensive lesions caused by the irradiation are often lethal and induce apoptosis in the affected cells during the first hours after irradiation. The observed sharp increase of the fragmented DNA content in blood plasma is a reflection of this process [10, 11] . Surprisingly, the early events following radiation exposure, such as apoptotic death of damaged cells, activation of DNA end-joining and activation of HR repair [9] are not the end but on the contrary the beginning of the development of life-threatening symptoms of radiation sickness that appear inevitably but not immediately after the exposure. The disease can last for months but the actual mechanism of its development is not clear. Some clues to understanding the disease propagation can be found in studies of the radiation bystander effect. It is asserted that the cells directly damaged by the irradiation release a relatively low molecular weight toxic agent, which affects the non-damaged "bystander" cells in a similar manner that the irradiation does, causing the same types of mutations, chromosome aberrations and cell death [12] . The effect of this putative agent could shed light on how the disease spreads and how the irradiation of an area of the body can cause radiation damage in remote non-irradiated parts, but the agent and mechanism of its action are still to be elucidated [12] .
These same points also relate to the effect of chemical mutagens. For example, a widely used chemotherapeutic drug, cyclophosphamide, induces multiple DSBs and resulting chromosome aberrations in treated organisms [13, 14] . The post-chemotherapy symptoms resemble those of radiation sickness. Ulceration of mucosae and skin, bruising, bleeding from nose and mouth, nausea and vomiting, diarrhea and bloody stool, decline of leukocytes and red blood cells, loss of immunity, and loss of hair are hallmarks of both radiation and chemotherapy [15] . As with the radiation bystander effect that affects healthy non-damaged cells long after the actual time of irradiation, cells treated with a chemical mutagen demonstrate delayed mutagenic action in the absence of the actual mutagen, and the agent of that delayed damage also remains unknown [16] . What kind of agents could be responsible for delayed mutagenic and clastogenic action induced by both radiation and chemotherapy?
Here we present our hypothesis that the extracellular mutant DNA from primarily damaged cells can be the agent spreading mutagenic damage in an organism. Based on the hypothesis we developed a DNA therapy, which may be able to stop this process and remove the damage. It was tested on mice exposed to -irradiation or treated with mutagen cyclophosphamide. We observed a dramatic increase in survival of the lethally irradiated animals and accelerated recovery of those treated with the chemical mutagen.
Hypothesis on genotoxic mutated DNA fragments
Recently we supposed that there exists a natural mechanism, which manages the genetic content of cells in a multicellular organism using extracellular fragments of its own genomic DNA from biological fluids as an external standard [17] . According to the proposed mechanism cell surface nucleic acid binding receptors bind and deliver genomic DNA fragments from the outside of the cell to the nuclei, where they substitute for the corresponding homologous fragments in cellular genomic DNA via HR. The experimental tests were consistent with the proposed mechanism, in that the external genomic fragments were found capable to alter specifically cancer cell properties lowering expression level of cancer marker proteins in vitro and the immune status of mice in vivo [17] . Here we will consider the components of this mechanism and how it can use mutated DNA fragments from the mutagenically damaged cells in development of mutational damage in an organism.
Extracellular DNA of blood circulation
Extracellular genomic DNA fragments originating presumably from apoptosis of cells are always present in tissue fluids and blood plasma. The phenomenon has been extensively studied and the results were discussed recently in several reviews [18] [19] [20] highlighting four main features. 1) The length of the circulating fragments corresponds to the length of a nucleosome, the structural unit of nuclear chromatin, multiplied by a factor of 1-5, i.e., 200-1000 bp.
2) The estimated half-life time of the DNA fragments in circulation is only several minutes, not because of their degradation, as no shorter fragments were detected in the blood, but presumably because of their being taken up by cells of the surrounding tissues [21] . 3) Concentration of the DNA fragments in plasma of young healthy individuals is usually below 10 ng/ml, but increases considerably up to 100-300 ng/ml during inflammatory diseases, fever and cancer, and up to 500-1500 ng/ml in SLE patients [19] . Radiation exposure results in a sharp increase in these DNA fragments in animals [10, 11] . 4) The circulating DNA fragments collectively comprise the entire genomes of cellular populations of the organism, including those with mutations, which permits their use for diagnostic purposes, whereas the biological significance of this DNA in an organism remains unclear.
DNA transportation into nuclei
It was found that cells possess a specific receptor-mediated mechanism enabling them to internalize DNA fragments and deliver them (across the acidic cellular compartment) to the cytosol and the 
Somatic homologous recombination
Homologous recombination in somatic cells differs considerably from that occurring in genital cells during meiosis and is not associated with any specific stage of the cell cycle or with specific chromosomal events or structure, such as chromosome conjugation or formation of synaptenemal complexes followed by crossing over. Somatic cell HR therefore resembles HR in bacteria. Having sufficient homology, the DNA molecules that are delivered into the somatic cell nuclei recombine among themselves or with genomic DNA via HR and DNA fragments as short as 100 nucleotides can be incorporated into the genome by this mechanism [1, 39, 40 ]. 14 -25 bp is the minimal length of homologous sequence in mammalian cells that is required to yield recombinant product, the yield Hoeijmeikers in Nature suggests a crucial role for DNA ends in homology search complex formation in HR DSB repair [1] . Based on the scheme by Hoeijmeikers we proposed our scheme illustrating how a fragment of a host genomic DNA can be substituted by an internalized extracellular homologous DNA fragment using the same molecular machinery (Fig. 1) . Importantly, according to the scheme the exact homology is necessary only for the flanking single-stranded parts of the fragment while the main middle part of the internalized DNA is incorporated into the genome without further verification.
Functioning of the proposed mechanism at mutational damage
The above mentioned elements might all be a part of a novel DNA repair mechanism, capable of eliminating any established or new mutation from a cellular genome. The effectiveness of this process would certainly depend on the quality and properties of the external DNA standard. On the one hand, this mechanism could eliminate a mutation from a cell by substituting it with an exogenous nonmutated sequence; on the other hand, it could introduce a mutation into a cell by substitution of a healthy cell sequence with a mutated exogenous homologue. The latter especially applies to the situation right after the ionizing irradiation or other mutagen exposure of the organism. As was mentioned in the Introduction section, the irradiation is always followed by an increase in the apoptotic DNA content in the circulating blood, originating from lethally irradiated cells. Similarly chemical mutagens induce apoptosis in the affected cells that certainly release their fragmented DNA [47, 48] . This DNA inevitably contains numerous varied mutations, including lethal. The DNA transporting mechanism will deliver all these fragments into cells and HR will incorporate them into the cellular genomes. Subsequently, the cells that received the DNA fragments carrying lethal mutations will die and then release their genomic DNA containing the mutant sequences into the surrounding medium. Cells that receive non-lethally mutated sequences will survive and then might compose a starting population for a cancer clone selection. Among these apoptotic fragments can certainly be those, corresponding to the areas of DSB repaired by non-homologous end joining with incorrectly joined DNA ends. Such fragments will contain junctions of sequences belonging to two different regions of the genome from the same or different chromosomes. The fragments, containing such "chimeric" DNA with the junction site, will be incorporated into the cellular genome according to the homology found for their ends. However since the ends of such fragments may belong to different regions of the genome, the incorporation may result in crosslinking of remote chromosomal segments or segments of different chromosomes accompanied by translocations and deletions including loss of arms/fragments of the participating chromosomes. During mitosis these rearrangements, invisible in the interphase chromatin, will lead to various chromosome aberrations, the type of which will depend on the initial location of the joined genomic sequences comprising a "chimeric" joint fragment and will be exactly the same as that in the cell originally damaged by the irradiation. Fig. 2 is an illustration of how multiple DSBs and the randomly joined ends can result in formation of dicentromeric chimerical chromosome leading to severe chromosome aberration and how the chimeric joint DNA fragment liberated after the cell death can induce identical aberration in a healthy cell being delivered into its nucleus. (p = 0.076, slightly above the value of 0.05 that implies significance to 95% probability). At 130 days after the irradiation, the surviving mice appeared healthy, but their fur initially brownish in color turned gray-haired (almost white), which normally never occurs in these mice, even at the older age (Fig. 4) . Although all mice became gray-haired they had an unusual distribution of the gray color on their bodies with grayish spots and lines on their backs and almost normal brownish color on the snouts.
Recovery of mice using genomic DNA segments after being treated by chemical mutagen xenogenic human DNA at the same dose and scheme as the group treated with mouse DNA. CBA mice groups were treated with DNA preparations and saline using scheme and doses applied to A/Sn mice: one group was treated with CBA mouse DNA, syngenic for CBA mice, another two groups with human and salmon xenogenic DNA preparations, and control group with saline as placebo. Total blood leukocytes were counted on the 3 rd , 5 th and 7 th day of the experiment. On day 3 of the experiment the leukocyte count dropped approximately 20 -fold in all groups of both strains of mice, however the lymphocyte count remained ~1.5 times higher in the mouse DNA groups than in xenogenic and control groups (Figs. 5 and 6). At day 4 two mice of the control group of A/Sn strain receiving saline died. As seen from the graph in Fig. 5 the lymphocyte count in the group of mice treated with mouse DNA returned to normal by day 7 of the experiment exceeding that of the saline control group almost twice, and the group treated with human DNA 1.5 times. In CBA mice groups treated with all DNA preparations the leukocytes returned to normal by day 5 of the experiment and in the mice treated with mouse DNA it was 200% of normal by day 7, exceeding control and salmon DNA group levels two-fold and three-fold, respectively and exceeding the leukocyte count in human DNA group with confidence by slightly less than 95%.
Discussion
The experimental results were consistent with the predictions of the hypothesis. Treatment of lethally irradiated mice with mouse DNA, which had the greatest potential to replace radiation-damaged DNA with wild type DNA, displayed the greatest survival benefit. The pre-injected mouse DNA was half as efficient, with two plausible explanations: first, the injected DNA was irradiated in mice and probably damaged together with the host DNA, and second, this group of mice were not injected with DNA on the 2 nd and 3 rd days after the irradiation. Independently of which reason was most important in diminishing of the effect, the most important conclusion from this result is that even single DNA injection and even before the irradiation can produce considerable survival benefit for the mice.
Human DNA, which could compete with the radiation-damaged sequences for entering the cells but is theoretically not useful for replacing damaged segments, had little if any effect on the survival rate.
The recovery after the cyclophosphamide injection had a similar pattern: mouse DNA was the most potent, human was less and salmon DNA was the least effective. Importantly, in this chemical mutagen experiments the administered CBA mouse DNA allogenic for A/Sn strain and syngenic for CBA strain mice worked similarly and was most potent in both mouse strains. We postulate that since the greatest damage caused by -irradiation and cyclophosphamide is multiple double-strand breaks resulting in chromosome aberrations, the therapeutic effect was due to elimination of this damage or its cause by the genomic DNA fragments. The fact that the proper species genomic DNA, rather than xenogenic DNA, was the most efficient agrees with the proposed mechanism.
It is noteworthy that we found several indications of the existence of this mechanism in the literature.
Assuming that the proposed mechanism works permanently and slowly, its functioning should not be obvious under normal circumstances; however, the disruption of its function may be noticeable.
Although mutations affecting the DNA-transporting mechanisms have not been identified yet, it is known that the mutations involved in HR molecular machinery induce a number of hereditary diseases associated with high IR sensitivity and predisposition to cancer [1] .
Study of the mutagenic effects of DNA made on Drosophila by S. M. Gershenzon and collaborators targeting methods can be explained by the fact that they do not fit well the features of natural mechanism that they intend to employ. Indeed based on the above considerations (see Introduction and Hypothesis sections) the constructs intending to employ full strength of the HR mechanism should have free DNA ends with perfect homology to the target sequence, which is necessary for the homology search. It can not be too long because the length of conversion tracts rarely exceeds 1,000 bp and it should not overburden a slow HR mechanism as it may cause nonhomologous insertions.
Interestingly, naturally circulating apoptotic fragments seem to fit very well the above optimal requirements for somatic homologous recombination. Also, despite extremely low reported efficiency of some gene targeting approaches, SFHR using DNA fragments with the length of a few hundred nucleotides was found effective. Additional evidence of a very high efficiency of somatic HR in cell can be found in the following facts. Since the failure of a DSB to get repaired ultimately causes cell death, and HR is the only known error-free DSB repair mechanism in cells, selection has resulted in close to 100% effectiveness for this process [1] . Also while describing the invention of the gene targeting method, the Capecchi [57] stressed extremely high efficiency of HR in somatic cells by the following example: when delivered into cell nuclei, the plasmids always integrated into cellular genomes in the form of a single concatemer consisting of all injected plasmids assembled head to tail by HR. Not one out of more than a hundred plasmids injected per cell could escape the HR machine from being incorporated into a single concatemer [57] . Equally, a genomic fragment, which enters the nucleus and has optimal size and absolute homology at its ends with the corresponding cellular genomic sequences, should have a chance close to 100% to be incorporated by HR into the cellular genome.
Homologous recombination was invented by microbial evolution 3.8 giga-years ago for the necessity of shuffling of minor genomic variants in a population via transferring of genomic fragments from outside of the cell followed by their incorporation into cellular genomes in corresponding homologous regions [59] . Although 3 giga-years later the eukaryotes and then multicellular organisms were created, the key proteins of the HR molecular machine preserved high homology from bacteria to mammals and still have the same functions: search for homology and recombination. It is reasonable to expect that the goal of their work should also remain the same.
Conclusion
Our hypothesis suggests that somatic cell genetics can be altered via external genomic DNA fragment Blood sampling and counting. Blood samples for leukocyte counting were collected from mice via tail sectioning essentially as described in [60] . Using a sterile scalpel blade, less than 2 mm of mouse tail was cut off and dripping blood was collected into a blood-collecting tube. Collected peripheral blood was diluted 100 times with physiological salt solution and counted in a hemacytometer.
Genomic DNA preparations. The DNA for therapeutic genomic DNA preparations was isolated from mouse livers, spleens and kidneys, or human placentas, according to a phenol-free method using 
